Phaon aims at……increasing patient benefit through addressing medical need with selection of effective agents … personalizing therapy through individualized, biomarker-driven treatments concepts that address breast cancer heterogeneity… accelerating drug development through introduction of early study endpoints (including early biological signals and clinical efficacy endpoints)Learn more
Breast cancer …… is the most common cancer among women and one in eight women will eventually be diagnosed with the disease.… prognosis has improved steadily. However, yet 1 in 10 breast cancer patients die within 5 years after primary diagnosis… is composed of several (molecularly distinct) subtypes. These subtypes require molecular, personalized and individualized treatment concepts.… presents with a large number of molecular targets. An increasing number of substances warrant novel scientific approaches to individualized therapyLearn more
Phaon scientific is a study development group offering a platform for professionals to discuss, promote, and perform research in the field of oncology.Learn more
We develop comprehensive and thorough trial concepts.
We make sure that trial costs stay focused on essential aspects.
Last Step: Publish
We ensure timely reporting and dissemination of study results.